| (HKD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 75.26B | — |
| Operating expense | — | — |
| Net income | 1.42B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2607.HK returned -2.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +6.4% |
| 1 year | -2.9% |
| 5 years | -8.4% |
| 10 years | -23.5% |
| All-time high | $25.70 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2607.HK would be worth today ›Yes. Shanghai Pharmaceuticals Holding Co., Ltd paid 2 dividends over the past 12 months. The most recent was $0.40 per share on Jul 15, 2026. The dividend yield is 4.60%.
Shanghai Pharmaceuticals Holding Co., Ltd is part of the Healthcare sector.
Shanghai Pharmaceuticals Holding Co., Ltd has a market cap of 42.72B HKD, based on the latest quote.
Shanghai Pharmaceuticals Holding Co., Ltd is scheduled to report earnings on Aug 27, 2026.
